down arrow

Boji Medical Technology Co., Ltd.

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: CNE100001Y00
  • SHE: 300404
CNY
15.17
0.31 (2.09%)

Sep 23

SHE

 View all stocks in this country
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

Comparison

Company
Score
Quality
Valuation
Financial
Technical
Boji Medical Technology Co., Ltd.

Why is Boji Medical Technology Co., Ltd. ?

1
With a growth in Net Profit of 322.01%, the company declared Outstanding results in Mar 26
  • The company has declared positive results for the last 2 consecutive quarters
  • OPERATING CASH FLOW(Y) Highest at CNY 69.93 MM
  • INVENTORY TURNOVER RATIO(HY) Highest at 3.11 times
  • NET SALES(Q) At CNY 220.16 MM has Grown at 58.54%
2
With ROE of 3.99%, it has a fair valuation with a 1.22 Price to Book Value
  • Over the past year, while the stock has generated a return of -2.93%, its profits have risen by 151.1% ; the PEG ratio of the company is 0.2
  • At the current price, the company has a high dividend yield of 0.3
stock-recommendationReal-Time Research Report

Verdict Report

How much should you buy?

  1. Overall Portfolio exposure to Boji Medical Technology Co., Ltd. should be less than 10%
  2. Overall Portfolio exposure to Pharmaceuticals & Biotechnology should be less than 30%

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock

Is Boji Medical Technology Co., Ltd. for you?

High Risk, High Return

Absolute
Risk Adjusted
Volatility
Boji Medical Technology Co., Ltd.
50.5%
0.64
47.45%
China Shanghai Composite
3.0%
1.20
14.07%
stock-recommendationQuality
stock-summaryManagement Risk
stock-summaryGrowth
stock-summaryCapital Structure
stock-recommendation
Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor
Value
Sales Growth (5y)
26.51%
EBIT Growth (5y)
0.34%
EBIT to Interest (avg)
9.99
Debt to EBITDA (avg)
0
Net Debt to Equity (avg)
-0.26
Sales to Capital Employed (avg)
0.70
Tax Ratio
3.47%
Dividend Payout Ratio
16.33%
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
2.37%
ROE (avg)
4.53%
stock-recommendationValuation

Valuation Scorecard stock-summary

stock-recommendation
Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors stock-summary

Factor
Value
P/E Ratio
75
Industry P/E
Price to Book Value
2.99
EV to EBIT
85.98
EV to EBITDA
48.69
EV to Capital Employed
3.98
EV to Sales
2.99
PEG Ratio
0.50
Dividend Yield
0.29%
ROCE (Latest)
4.63%
ROE (Latest)
3.99%
stock-recommendationTechnicals

Technical key factors

Indicator
Weekly
Monthly
MACD
Bullish
Bullish
RSI
No Signal
Bearish
Bollinger Bands
Bullish
Bullish
Moving Averages
Bullish (Daily)
KST
Bullish
Bullish
Dow Theory
Mildly Bullish
No Trend
OBV
Mildly Bearish
No Trend
stock-recommendation Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
Technical Movement
Analyse All Technical Factors stock-recommendation
stock-recommendationFinancial Trend

Financial Trend Scorecard stock-summary

stock-recommendation
Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

27What is working for the Company
OPERATING CASH FLOW(Y)

Highest at CNY 74.67 MM

NET SALES(HY)

At CNY 454.14 MM has Grown at 25.64%

ROCE(HY)

Highest at 5%

CASH AND EQV(HY)

Highest at CNY 802.14 MM

DEBT-EQUITY RATIO (HY)

Lowest at -33.55 %

PRE-TAX PROFIT(Q)

Highest at CNY 19.75 MM

NET PROFIT(Q)

Highest at CNY 19.84 MM

EPS(Q)

Highest at CNY 0.05

-1What is not working for the Company
RAW MATERIAL COST(Y)

Grown by 22.3% (YoY

Here's what is working for Boji Medical Technology Co., Ltd.

Pre-Tax Profit
At CNY 19.75 MM has Grown at 105.61%
Year on Year (YoY)
MOJO Watch
Near term Pre-Tax Profit trend is very positive

Pre-Tax Profit (CNY MM)

Net Sales
At CNY 454.14 MM has Grown at 25.64%
Year on Year (YoY)
MOJO Watch
Near term sales trend is positive

Net Sales (CNY MM)

Operating Cash Flow
Highest at CNY 74.67 MM
in the last three years
MOJO Watch
The company has generated higher cash revenues from business operations

Operating Cash Flows (CNY MM)

Pre-Tax Profit
Highest at CNY 19.75 MM
in the last five periods
MOJO Watch
Near term Pre-Tax Profit trend is positive

Pre-Tax Profit (CNY MM)

Net Profit
Highest at CNY 19.84 MM
in the last five periods
MOJO Watch
Near term Net Profit trend is positive

Net Profit (CNY MM)

Net Profit
At CNY 19.84 MM has Grown at 76.39%
Year on Year (YoY)
MOJO Watch
Near term Net Profit trend is positive

Net Profit (CNY MM)

EPS
Highest at CNY 0.05
in the last five periods
MOJO Watch
Increasing profitability; company has created higher earnings for shareholders

EPS (CNY)

Cash and Eqv
Highest at CNY 802.14 MM
in the last six Semi-Annual periods
MOJO Watch
Short Term liquidity is improving

Cash and Cash Equivalents

Debt-Equity Ratio
Lowest at -33.55 %
in the last five Semi-Annual periods
MOJO Watch
The company has been reducing its borrowing as compared to equity capital

Debt-Equity Ratio

Here's what is not working for Boji Medical Technology Co., Ltd.

Raw Material Cost
Grown by 22.3% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has deteriorated; this may lead to a fall in profit margin

Raw Material Cost as a percentage of Sales

Footer loading